NDC 61958-3104 – Hepcludex
Bulevirtide Acetate 8.5 mg/1 · Injection, Powder, Lyophilized, For Solution · Subcutaneous
Product NDC61958-3104
Product details
- Brand name
- Hepcludex
- Generic name
- Bulevirtide
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761468
- Marketed since
- May 22, 2026
- Listing expires
- December 31, 2027
Active ingredients
- Bulevirtide Acetate 8.5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61958-3104-1 | 30 VIAL, SINGLE-DOSE in 1 CARTON (61958-3104-1) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (61958-3104-2) | May 22, 2026 |